Φορτώνει......
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis
BACKGROUND: Use of the Xpert MTB/RIF assay has increased the number of people diagnosed with rifampicin-resistant tuberculosis (RR-TB), especially in South Africa where Xpert is now the initial diagnostic for individuals with TB symptoms. We hypothesized that a proportion of RR-TB patients determine...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Antimicrob Chemother |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148329/ https://ncbi.nlm.nih.gov/pubmed/29982641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky248 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|